Differences in clinical presentation and outcome between immune checkpoint inhibitor-associated myocarditis and classical acute myocarditis: Same disease, distinct challenges to face

Int J Cardiol. 2019 Dec 1:296:124-126. doi: 10.1016/j.ijcard.2019.08.038. Epub 2019 Aug 17.

Authors

Giacomo Veronese¹, Enrico Ammirati²

Affiliations

¹ De Gasperis Cardio Center, Niguarda Hospital, Milano, Italy; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy.
² De Gasperis Cardio Center, Niguarda Hospital, Milano, Italy. Electronic address: enrico.ammirati@ospedaleniguarda.it.

PMID: 31472949
DOI: 10.1016/j.ijcard.2019.08.038

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Immunologic Factors
Immunotherapy
Myocarditis*

Substances

Immunologic Factors